Q2FY21 to Rs. 0.07 crore in Q3FY21
- Business
Lasa Supergenerics Q3FY21 PAT at 6.56 Crores up by 154% YoY Finance Cost Reduced by 95.40% YoY
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial…
Read More »